The abscopal effect — can radiation make immunotherapy work better?

The abscopal effect is when radiation aimed at one tumour is followed by shrinkage of a completely different tumour somewhere else in the body — a tumour the radiation beam never touched. The name comes from roots meaning “away from the target”. It is real, documented, and rare.

The explanation researchers give runs like this. Radiation damages cancer cells in the treated area. As those cells break apart, they release proteins and fragments the immune system has not previously encountered. Immune cells can pick up that material, learn to recognise it, and then act on the same cancer in sites the beam never reached. Radiation, in this account, is doing something in addition to its direct local job: it is exposing the cancer.

That is where checkpoint inhibitor immunotherapy comes in. Checkpoint inhibitors aim to release a brake on those same immune cells. So the hypothesis, in one sentence, is that radiation supplies the signal and immunotherapy removes the brake. It is a clean idea, and it is why a term that sat almost unused for fifty years came back into wide discussion.

What the abscopal effect is not is a treatment. You cannot be given it, booked in for it, or prescribed it. It is a name for something that has occasionally been observed after treatment given for other reasons. Any page that presents it as something you can request is describing a hypothesis as though it were a procedure.

Whether radiation belongs anywhere in your plan is a decision for your treating team, taken with your cancer type, your imaging, what has already been irradiated, and how you are day to day. Nothing on this page can make that call, and it is not meant to.

Rarely. Published reviews of the case-report literature found fewer than fifty well-documented cases in the four decades before checkpoint inhibitors came into clinical use. It is reported more often now that radiation and immunotherapy are frequently given in the same period. It remains uncommon, and it remains unpredictable.

That number is a count of published case reports, not a rate. It cannot be turned into a chance for any individual patient, and this page will not pretend otherwise. The useful thing it tells you is the order of magnitude: this is a phenomenon documented case by case over seventy years, not an outcome a treating team can build a plan around.

Being clear about that is the point of this section. The abscopal effect is one of the most over-stated ideas in cancer information online, and families arrive at consultations having read that radiation can “switch on” the immune system against cancer everywhere in the body. Some of the disappointment that follows is avoidable, and it is avoided by saying the rare part out loud first.

Guideline bodies including NCCN, ASCO and ESMO discuss radiation with immunotherapy as appropriate in defined situations. None of them presents the abscopal effect as a reason to give radiation.

Not adding radiation is a real option and a common one. If there is no symptom to control and no site that needs treating, waiting and watching the scans is a legitimate plan — not a lesser one. Ask which of the two you are being offered, and why.

Because radiation has jobs of its own, and those jobs are the reason it is prescribed. Controlling pain from a bone deposit. Stopping bleeding. Relieving pressure on an airway or a nerve. Treating deposits in the brain. Consolidating a small number of remaining sites. Any immune effect elsewhere is secondary and unplanned.

1. 1

   Pain from a bone deposit

   The commonest reason radiation is added while someone is on immunotherapy. A short course to a painful site can reduce the pain and the amount of painkiller needed. It is given for the pain, not for the immune system.

2. 2

   Bleeding or an obstruction

   Radiation is used to control bleeding from a tumour, or to open up an airway, a swallowing tube or another passage that a tumour is pressing on. These are urgent, practical problems with an urgent, practical answer.

3. 3

   Pressure on a nerve or the spinal cord

   A deposit pressing on the spinal cord is an emergency, and radiation is one of the standard responses to it. Timing here is measured in hours and days, not in what would suit the infusion calendar.

4. 4

   Deposits in the brain

   Brain deposits are often treated with radiation whether or not immunotherapy is running, because most immunotherapy work in the brain is limited and the deposits need local control in their own right.

5. 5

   A small number of remaining sites

   When most of the cancer is controlled and one or two sites are not, radiation is sometimes used to deal with those sites specifically. This is the setting people most often confuse with the abscopal effect. It is not the same thing: the aim is control of the site being treated.

Notice what is absent from that list. None of these five is “to help the immunotherapy work better”. Where combining treatments is a planned strategy, it is a defined, guideline-backed regimen with a stated purpose — the way chemotherapy and immunotherapy are given together in several cancers. We cover that separately in Immunotherapy With Chemotherapy: Why Both Together?, and the contrast is instructive: that combination has a stated rationale and a set number of cycles. The abscopal effect has neither.

Yes, timing matters, and your treating team sets it. Radiation before immunotherapy, during it, or after it are all used. Each is chosen for practical reasons: how urgent the symptom is, how long recovery takes, and how side effects will be told apart afterwards. No sequence is known to reliably produce an abscopal effect.

Sequencing worries are not unique to radiation. The same “have we done these in the wrong order?” question comes up about what follows immunotherapy, and it is worth reading Does Immunotherapy Make Later Chemotherapy Work Better? if that is on your mind. The answer in both cases has the same shape: order is decided deliberately, by people looking at your reports together.

If your plan changes part-way through, ask what changed and why. Every reasonable team will explain the reasoning in plain language, and you are entitled to ask for it in writing.

It is not an improvised or unusual combination. Radiation and immunotherapy are given together routinely, in a planned sequence. The genuine issue is overlapping inflammation: radiation to the chest and immune inflammation of the lungs cause similar symptoms, so a new cough or breathlessness needs assessing quickly.

The lungs are the main overlap. Radiation to the chest can inflame lung tissue in the treated area, and checkpoint inhibitor immunotherapy can inflame lung tissue anywhere. The two look alike from the outside — a cough that is new, breathlessness on stairs you used to manage, a tightness that was not there last month. They are managed differently, so telling them apart matters, and that needs a scan and a review rather than a wait.

Skin, swallowing and the gut are the other overlaps. Skin in the treated area can react more than expected. If the swallowing tube is in the field, swallowing can become sore. If part of the bowel is in the field, loose motions can appear — and loose motions are also one of the immune reactions that must never be self-treated at home.

Scans get harder to read, and that is expected. A treated area can look inflamed on imaging for weeks afterwards, which is a known reason a response scan may be reported cautiously or repeated. Response-assessment imaging for CION patients is coordinated at partner imaging centres, and the reports are read alongside the radiation plan rather than in isolation.

When to call rather than wait. A new or worsening cough, new breathlessness, chest pain, severe abdominal pain, or loose motions more often than usual should go to your oncology team the same day — or to the CION helpline on 1800 202 8726. If you cannot reach anyone, go to the emergency department now and tell them you are on immunotherapy and have had radiation. Do not wait for your next appointment, and do not treat these at home.

Most of the anxiety around combining these two treatments comes from not knowing which decisions have already been taken, and on what grounds. These five questions get you that in a single conversation.

• What is the radiation actually for — which symptom or which site — and what happens if we do not give it?
• Do my infusions continue through the radiation course, pause, or restart afterwards?
• Has this area been irradiated before, and does that change what can be given now?
• Which symptoms afterwards should I report the same day, and which can wait for my next visit?
• How will we tell a radiation side effect apart from an immune reaction if one appears?

Related reading. Sequencing questions rarely arrive one at a time. If you are weighing how immunotherapy sits alongside another treatment, Immunotherapy and Hormone Treatment Together covers the same ground for hormone-driven cancers. For how immunotherapy is delivered at our centres — as day care, with response scans coordinated at partner imaging centres — see Immunotherapy at CION Cancer Clinics. A 45-minute consultation is designed to leave you with the reasoning in writing rather than in memory.

This page is general information and does not replace a consultation. It describes treatment classes only, not specific medicines or regimens, and it recommends no treatment. The abscopal effect is described here as a documented but rare and unpredictable phenomenon; nothing on this page implies it can be produced, requested or expected, and no outcome figure of any kind is stated or implied. Trial information is included to explain how the question is being studied, not to invite enrolment. The combination rationale and side-effect patterns are drawn from NCCN, ASCO and ESMO patient-education guidance. Every decision about whether to give radiation, and in what order, belongs with your own treating team.

Get a second opinion on your combination plan

Free, written, and reviewed by our tumour board — so you know why each part of the plan is there, and what it is realistically for.